These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38945767)

  • 1. Crisis management in community pharmacies during a pandemic.
    Latonen S; Neuvonen E; Juppo AM; Seeck H; Airaksinen M
    Res Social Adm Pharm; 2024 Jun; ():. PubMed ID: 38945767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing the COVID-19 health crisis: a survey of Swiss hospital pharmacies.
    Schumacher L; Dhif Y; Bonnabry P; Widmer N
    BMC Health Serv Res; 2023 Oct; 23(1):1134. PubMed ID: 37864155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with health service orientation and active product marketing orientation in Finnish community pharmacies: a nationwide study among private pharmacy owners.
    Jokinen L; Puumalainen I; Airaksinen M
    BMC Health Serv Res; 2020 Jul; 20(1):667. PubMed ID: 32690013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organisation of cross-sector collaboration and its influence on crisis management effectiveness among pharmaceutical supply chain stakeholders during the COVID-19 pandemic.
    Latonen SH; Suominen RM; Juppo AM; Airaksinen M; Seeck H
    Public Health; 2023 Sep; 222():196-204. PubMed ID: 37567019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pandemic preparedness of community pharmacies for COVID-19.
    Bahlol M; Dewey RS
    Res Social Adm Pharm; 2021 Jan; 17(1):1888-1896. PubMed ID: 32417070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rural community pharmacies' preparedness for and responses to COVID-19.
    Carpenter DM; Hastings T; Westrick S; Rosenthal M; Mashburn P; Kiser S; Shepherd JG; Curran G
    Res Social Adm Pharm; 2021 Jul; 17(7):1327-1331. PubMed ID: 34155979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacy practice in emergency response during the COVID-19 pandemic: Lessons from Australia.
    Parajuli DR; Khanal S; Wechkunanukul KH; Ghimire S; Poudel A
    Res Social Adm Pharm; 2022 Aug; 18(8):3453-3462. PubMed ID: 34810136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Policy and vision for community pharmacies in Finland: A roadmap towards enhanced integration and reduced costs.
    Airaksinen M; Toivo T; Jokinen L; Savela E; Parkkamäki S; Sandler C; Kalliomäki H; Dimitrow M
    Pharm Pract (Granada); 2021; 19(1):2288. PubMed ID: 33628348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the COVID-19 Pandemic on the Public Perceptions of the Roles and Functions of Community Pharmacies in South Korea: Updated Cross-Sectional Self-Reported Web-Based Survey.
    Yang DW; Son KB
    JMIR Public Health Surveill; 2023 Jul; 9():e46723. PubMed ID: 37390391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of strategic planning on product marketing and health service orientation of community pharmacies-A national survey in Finland.
    Jokinen L; Puumalainen I; Airaksinen M
    Health Policy; 2019 May; 123(5):462-467. PubMed ID: 30808534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 15 Year Ecological Comparison for the Market Dynamics of Minnesota Community Pharmacies from 2002 to 2017.
    Olson AW; Schommer JC; Hadsall RS
    Pharmacy (Basel); 2018 Jun; 6(2):. PubMed ID: 29865252
    [No Abstract]   [Full Text] [Related]  

  • 12. The Particularities of Pharmaceutical Care in Improving Public Health Service during the COVID-19 Pandemic.
    Ghibu S; Juncan AM; Rus LL; Frum A; Dobrea CM; Chiş AA; Gligor FG; Morgovan C
    Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opinion comparison concerning future information technology in Finnish community pharmacies.
    Westerling AM; Hynninen JT; Haikala VE; Airaksinen MS
    Pharm World Sci; 2010 Dec; 32(6):787-94. PubMed ID: 20848207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacy practice architecture challenges in handling COVID-19 pandemic - sharing experience from a Kosovo pharmacy practice.
    Jakupi A; Jakupi AB
    Pharm Pract (Granada); 2021; 19(4):2597. PubMed ID: 35474644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacy Emergency Preparedness and Response (PEPR): a proposed framework for expanding pharmacy professionals' roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond.
    Aruru M; Truong HA; Clark S
    Res Social Adm Pharm; 2021 Jan; 17(1):1967-1977. PubMed ID: 32389631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community pharmacy during the COVID-19 pandemic: a cross-sectional study.
    Merks P; Świeczkowski D; Bilmin K; Jakubowska M; Drelich E; Lewicki J; Gołębiewska W; Bogusz J; Jaguszewski M
    Przegl Epidemiol; 2020; 74(4):620-633. PubMed ID: 33861029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical services cost analysis using time-driven activity-based costing: A contribution to improve community pharmacies' management.
    Gregório J; Russo G; Lapão LV
    Res Social Adm Pharm; 2016; 12(3):475-85. PubMed ID: 26365300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Norwegian Community Pharmacists' Experiences with COVID-19 Vaccination-A Qualitative Interview Study.
    Aarnes RV; Nilsen MK
    Pharmacy (Basel); 2023 Nov; 11(6):. PubMed ID: 37987391
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Patterson SM; Cadogan CA; Barry HE; Hughes CM
    BMJ Open; 2022 Sep; 12(9):e064549. PubMed ID: 36137632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive deviants for medication therapy management: A mixed-methods comparative case study of community pharmacy practices.
    Adeoye-Olatunde OA; Lake LM; Strohmier CA; Gourley AK; Ray AR; Zillich AJ; Snyder ME
    Res Social Adm Pharm; 2021 Aug; 17(8):1407-1419. PubMed ID: 33214124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.